SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-15-000725
Filing Date
2015-08-28
Accepted
2015-08-28 16:15:38
Documents
2
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT LLCCORMORANT GLOBAL HEALTHCARE GP LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND LP

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 120838
2 JOINT FILING AGREEMENT exhibit1.htm EX-1 8631
  Complete submission text file 0000929638-15-000725.txt   131384
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39444 | Film No.: 151082347
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Filed by) CIK: 0001618442 (see all company filings)

IRS No.: 981101801 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G